Evidence map›Paper›PMID 31848914›Full record

ArticleMolecular biology reports2020

Thioredoxin, thioredoxin interacting protein and transducer and activator of transcription 3 in gestational diabetes.

Yael Pasternak, Meital Ohana, Tal Biron-Shental, Keren Cohen-Hagai, Sydney Benchetrit, Tali Zitman-Gal

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yael PasternakDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
Meital OhanaNephrology Laboratory, Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Tal Biron-ShentalDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
Keren Cohen-HagaiNephrology Laboratory, Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Sydney BenchetritSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tali Zitman-GalSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. tali.gal@clalit.org.il.
Meir Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate changes in the inflammatory response of thioredoxin (TXN), thioredoxin interacting protein (TXNIP), transducer and activator of transcription 3, NFƙB-p50 and STAT3 at the level of maternal serum, placenta, and umbilical cord blood of women with gestational diabetes mellitus type 2 (GDMA2) compared to normal pregnancies (NP). Thirty pregnant women (20 with GDMA2 and 10 NP) were recruited during admission for delivery. Blood samples were obtained from the parturients and umbilical cords, as well as placental tissue for mRNA and protein extraction. TXNIP mRNA expression was significantly increased in maternal serum of women with GDMA2 compared to NP women. TXNIP mRNA was significantly decreased in GDMA2 placentas and cord blood compared to NP. TXN/TXNIP mRNA ratio showed significantly high absolute values in placental and cord blood (2.39 and 1.66) respectively, compared to maternal ratio (1.084) (P < 0.001). TXN/TXNIP placenta protein ratio showed similar values between GDMA2 and NP (0.98 and 0.86; P = 0.7). STAT3 and its target protein SOCS3, as well as NFƙB-p50 mRNA expression were significantly increased in placentas of GDMA2. NFƙB-p50 mRNA expression was significantly decreased in cord blood compared to both maternal and placental mRNA expression. Pro-inflammatory changes are expressed by low mRNA TXN/TXNIP ratio in maternal blood of GDMA2 patients, but not in placental and umbilical cord blood samples. This, as well as the feedback role of SOCS3 in STAT3 pathway and NFƙB-p50 expression, may indicate that the placenta has a role in protecting the fetus from damage due to inflammatory response, which is common in diabetes.

Indexed as

Carrier ProteinsDiabetes, GestationalFemaleGene ExpressionHumansModels, BiologicalNF-kappa B p52 SubunitOxidative StressPlacentaPregnancyProtein BindingReactive Oxygen SpeciesRNA, MessengerSignal TransductionSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinCarrier ProteinsNF-kappa B p52 SubunitReactive Oxygen SpeciesRNA, MessengerSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinThioredoxinsTXNIP protein, humanTXN protein, humanGDMA2NFƙB-p50SOCS3STAT3TXNTXNIP

Identifiers

PMID31848914
OpenAlexW2995430956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.